AnaptysBio, Inc (ANAB) stock
ANABNasdaqPharmaceutical PreparationsFiscal year ends June 30
$49.24+2.63 (+5.64%)
Close on Oct 19, 2026Market cap $2.28BP/E –Yield –
AnaptysBio price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
AnaptysBio's price to book ratio was 138.3× on Oct 19, 2026, against 6.4× a year earlier. Over the last 5 years it ranged from 1.1× to 160.2×, with a median of 2.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 138.3× | +123.7 |
| 2025 | Jul 31, 2025 | 14.6× | +11.4 |
| 2024 | Dec 31, 2024 | 3.2× | +0.0 |
| 2023 | Dec 29, 2023 | 3.2× | +1.0 |
| 2022 | Dec 30, 2022 | 2.1× | +0.5 |
| 2021 | Dec 31, 2021 | 1.7× | +0.6 |
| 2020 | Dec 31, 2020 | 1.1× | +0.4 |
| 2019 | Dec 31, 2019 | 0.7× | −1.6 |
| 2018 | Dec 31, 2018 | 2.3× | −11.3 |
| 2017 | Dec 29, 2017 | 13.6× | – |
See a number that looks wrong?